Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001329549 | SCV001521010 | uncertain significance | Pontocerebellar hypoplasia type 3 | 2019-12-24 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV001871800 | SCV002210579 | uncertain significance | not provided | 2022-07-26 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 1028494). This variant has not been reported in the literature in individuals affected with PCLO-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces aspartic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 1631 of the PCLO protein (p.Asp1631Val). |
Daryl Scott Lab, |
RCV001329549 | SCV002515347 | uncertain significance | Pontocerebellar hypoplasia type 3 | 2022-02-01 | criteria provided, single submitter | clinical testing |